News
Brokers Suggest Investing in MercadoLibre (MELI): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Lemonade (LMND) Just Overtook the 50-Day Moving Average
After reaching an important support level, Lemonade (LMND) could be a good stock pick from a technical perspective. LMND surpassed resistance at the 50-day moving average, suggesting a short-term
Pinnacle West (PNW) Matches Q2 Earnings Estimates
Pinnacle West (PNW) came out with quarterly earnings of $1.58 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.76 per share a year ago. These figures are
Wall Street Bulls Look Optimistic About Emcor Group (EME): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Company News for Aug 6, 2025
- Shares of Pfizer Inc. (PFE) jumped 5.2% after the company reported second-quarter 2025 earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share.
- Marathon Petroleum
TPG Inc. (TPG) Q2 Earnings and Revenues Surpass Estimates
TPG Inc. (TPG) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.49 per share a year ago. These figures
CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View
Charles River Laboratories International, Inc. CRL reported second-quarter 2025 adjusted earnings per share (EPS) of $3.12, which rose 11.4% year over year. The figure surpassed the Zacks Consensus
Stock Market News for Aug 6, 2025
U.S. stocks ended lower on Tuesday as investors weighed the impact of tariffs after a slew of companies cited higher duties in their earnings reports, and weaker-than-expected economic data dented
3 Stocks Riding the AI Data Center Buildout Wave
Earnings season follows a predictable rhythm. Investors have now heard from many companies fueling the artificial intelligence (AI) revolution. This earnings season, hyperscalers like Amazon
JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut
Jazz Pharmaceuticals JAZZ reported second-quarter 2025 adjusted loss of $8.25 per share, wider than the Zacks Consensus Estimate of a loss of $6.12. This downtick was primarily due to a one-time
BMY Stock Trades Near 52-Week Low: Time to Buy or Sell?
Share price of Bristol Myers Squibb (BMY) touched a 52-week low of $42.96 on July 31, post its second-quarter earnings release. The stock has recovered 6.7% since then and is currently trading at
MPLX Q2 Earnings Miss Estimates on Higher Operating Expenses
MPLX LP MPLX reported second-quarter 2025 earnings of $1.03 per unit, which missed the Zacks Consensus Estimate of $1.07. The bottom line also declined from the year-ago quarter’s level of $1.15.
Unlocking Q2 Potential of UWM (UWMC): Exploring Wall Street Estimates for Key Metrics
The upcoming report from UWM Holdings Corporation (UWMC) is expected to reveal quarterly earnings of $0.06 per share, indicating an increase of 50% compared to the year-ago period. Analysts
Ahead of Mercury Systems (MRCY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Mercury Systems (MRCY) will report quarterly earnings of $0.21 per share in its upcoming release, pointing to a year-over-year decline of 8.7%. It is anticipated
U.S. Cellular (USM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Analysts on Wall Street project that United States Cellular (USM) will announce quarterly earnings of $0.33 per share in its forthcoming report, representing an increase of 65% year over year
Stay Ahead of the Game With Consolidated Water (CWCO) Q2 Earnings: Wall Street's Insights on Key Metrics
The upcoming report from Consolidated Water (CWCO) is expected to reveal quarterly earnings of $0.20 per share, indicating a decline of 23.1% compared to the year-ago period. Analysts forecast
Unlocking Q1 Potential of Haemonetics (HAE): Exploring Wall Street Estimates for Key Metrics
In its upcoming report, Haemonetics (HAE) is predicted by Wall Street analysts to post quarterly earnings of $1.01 per share, reflecting a decline of 1% compared to the same period last year
Stay Ahead of the Game With Plug Power (PLUG) Q2 Earnings: Wall Street's Insights on Key Metrics
The upcoming report from Plug Power (PLUG) is expected to reveal quarterly loss of -$0.15 per share, indicating an increase of 58.3% compared to the year-ago period. Analysts forecast revenues of
Gear Up for PENN Entertainment (PENN) Q2 Earnings: Wall Street Estimates for Key Metrics
Wall Street analysts expect PENN Entertainment (PENN) to post quarterly loss of -$0.04 per share in its upcoming report, which indicates a year-over-year increase of 77.8%. Revenues are expected
Insights Into American Healthcare REIT (AHR) Q2: Wall Street Projections for Key Metrics
The upcoming report from American Healthcare REIT (AHR) is expected to reveal quarterly earnings of $0.40 per share, indicating an increase of 21.2% compared to the year-ago period. Analysts
Exploring Analyst Estimates for Acushnet (GOLF) Q2 Earnings, Beyond Revenue and EPS
Wall Street analysts expect Acushnet (GOLF) to post quarterly earnings of $1.33 per share in its upcoming report, which indicates a year-over-year increase of 19.8%. Revenues are expected to be
Stay Ahead of the Game With Prestige Consumer Healthcare (PBH) Q1 Earnings: Wall Street's Insights on Key Metrics
Analysts on Wall Street project that Prestige Consumer Healthcare (PBH) will announce quarterly earnings of $1.01 per share in its forthcoming report, representing an increase of 12.2% year over
Seeking Clues to TDS (TDS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
In its upcoming report, Telephone & Data Systems (TDS) is predicted by Wall Street analysts to post quarterly loss of -$0.01 per share, reflecting an increase of 92.3% compared to the same period
Gear Up for Maximus (MMS) Q3 Earnings: Wall Street Estimates for Key Metrics
Analysts on Wall Street project that Maximus (MMS) will announce quarterly earnings of $1.39 per share in its forthcoming report, representing a decline of 20.1% year over year. Revenues are
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics
In its upcoming report, Elanco Animal Health Incorporated (ELAN) is predicted by Wall Street analysts to post quarterly earnings of $0.20 per share, reflecting a decline of 33.3% compared to the


